IPO Doors Creak Open as Mineralys Seeks $192M

IPO Doors Creak Open as Mineralys Seeks $192M

Source: 
BioSpace
snippet: 

Hypertension-focused Mineralys Therapeutics announced its upsized initial public offering Thursday, putting 12,000,000 shares of common stock for sale for $16.00 per share – and infusing a little hope into a bear biopharma market.